EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Magdi H. Yacoub
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abunasra, H. J.
Right arrow Articles by Yacoub, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abunasra, H. J.
Right arrow Articles by Yacoub, M. H.
Related Collections
Right arrow Molecular biology
Right arrow Myocardial protection

Eur J Cardiothorac Surg 2001;20:153-158
© 2001 Elsevier Science NL

Efficacy of adenoviral gene transfer with manganese superoxide dismutase and endothelial nitric oxide synthase in reducing ischemia and reperfusion injury

Haitham J. Abunasraa, Ryszard T. Smolenskia, Karren Morrisona, John Yapa, Mary N. Sheppardb, Timothy O'Brienb, Ken Suzukia, Jay Jayakumara, Magdi H. Yacouba

a Heart Science Centre, Imperial College School of Medicine at Harefield Hospital, Harefield, Middlesex UB9 6JH, UK
b Division of Endocrinology, Mayo Clinic, Rochester, MN, USA

Received 8 October 2000; received in revised form 16 March 2001; accepted 23 March 2001.

Corresponding author. Tel.: +44-1895-828893 fax: +44-1895-828902

Objective: Both superoxide dismutase (SOD), a free radical scavenger, and nitric oxide (NO), a vasodilator with anti-inflammatory properties, have been shown to protect the myocardium from reperfusion injury. They are known to interact in vivo, the influence of which on myocardial protection has not been studied. Methods: Four groups of rats (n=7, per group) were subjected to experimental infarction following injections into the anterior wall of the left ventricle with adenoviral vector encoding ß-galactosidase (group A), eNOS (group B), Mn-SOD (group C) and both eNOS and MnSOD (group D). Hearts were assessed for protein expression and size of infarction. Results: Efficiency of gene up regulation was confirmed by immunostaining for eNOS and Mn-SOD, and X-gal staining for ß-gal respectively. In B and D, overexpression of eNOS was demonstrated in cardiac myocytes in addition to that in the endothelium, while in C and D, Mn-SOD was overexpressed in mainly cardiomyocytes. Infarct size was 49.7±4.8% in A, and was significantly reduced in the other groups (29.8±2.7%, 21.8±2.5% and 24.9±2.4% in B, C and D respectively). Conclusion: Adenoviral gene transfer of Mn-SOD was superior to eNOS in reducing the extent of in vivo ischemia-reperfusion injury in the rat heart in our model. The effect of combined application of Mn-SOD and eNOS was not different from their individual effect.

Key Words: Adenovirus • Gene transfer • Myocardial infarct, Ischemia/reperfusion • Nitric oxide synthase • Superoxide dismutase




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger
Designing Heart Performance by Gene Transfer
Physiol Rev, October 1, 2008; 88(4): 1567 - 1651.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
C.-Y. Chen, B.-C. Lee, H.-C. Hsu, H.-J. Lin, C.-L. Chao, Y.-H. Lin, Y.-L. Ho, and M.-F. Chen
A proteomic study of the effects of ramipril on post-infarction left ventricular remodelling in the rabbit
Eur J Heart Fail, August 1, 2008; 10(8): 740 - 748.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A.-L. Levonen, E. Vahakangas, J. K. Koponen, and S. Yla-Herttuala
Antioxidant Gene Therapy for Cardiovascular Disease: Current Status and Future Perspectives
Circulation, April 22, 2008; 117(16): 2142 - 2150.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Fukushima, S. R. Coppen, A. Varela-Carver, K. Yamahara, P. Sarathchandra, R. T. Smolenski, M. H. Yacoub, and K. Suzuki
A Novel Strategy for Myocardial Protection by Combined Antibody Therapy Inhibiting Both P-Selectin and Intercellular Adhesion Molecule-1 Via Retrograde Intracoronary Route
Circulation, July 4, 2006; 114(1_suppl): I-251 - I-256.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Fukushima, S. R. Coppen, A. Varela-Carver, G. Brindley, K. Yamahara, P. Sarathchandra, M. H. Yacoub, and K. Suzuki
Enhanced efficiency of superoxide dismutase-induced cardioprotection by retrograde intracoronary administration
Cardiovasc Res, February 1, 2006; 69(2): 459 - 465.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. J. Abunasra, R. T. Smolenski, J. Yap, M. Sheppard, T. O'Brien, and M. H. Yacoub
Multigene adenoviral therapy for the attenuation of ischemia-reperfusion injury after preservation for cardiac transplantation
J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 998 - 1006.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. P. Jones, M. R. Hoffmeyer, B. R. Sharp, Y.-S. Ho, and D. J. Lefer
Role of intracellular antioxidant enzymes after in vivo myocardial ischemia and reperfusion
Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H277 - H282.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.